NAT10 and cancer: Remodelin, an inhibitor of NAT10 that is primarily used to relieve nuclear lamina defect-induced phenotypes, has been demonstrated to suppress a variety of human cancer cells, inhibiting their growth and cell cycle progression [12,13,14].